News

Torrent Pharma's India sales grew 11% year-on-year, led by out performance in the focused therapies as its chronic sales grew ...
Shares of Torrent Pharma fell as much as 2.61% to Rs 3,717.50 apiece. They pared gains to trade 2.35% higher at Rs 3,708.20 ...
Zen Technologies' Q1 results were muted given a slowdown in order inflow momentum that persisted for a fifth quarter in a row ...
BEL share price slips despite strong margins and order inflows; Nomura downgrades, while UBS and JP Morgan stay bullish.
Global brokerage Citi has maintained a 'Sell' rating with a target of ₹765 per share, according to reports. The brokerage ...
Of the 44 analysts that have coverage on IndusInd Bank, 24 of them continue to have a 'Sell' rating, 14 say 'Hold', while six ...
Minneapolis – Total home sales at Target were substantial in Q1, ringing in at more than $3.2 billion, but the trajectory continued downward.. First quarter sales in the retailer’s Home Furnishings & ...
Laurus Labs' share price surged 8% to an all-time high of ₹901, driven by strong Q1 FY26 earnings. Analysts raised target ...
Elevated slippages led to higher credit costs, and brokerages expects return on assets (RoAs) to stay below 1 percent in the near term.